Latest action: Referred to the House Committee on Energy and Commerce.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill funds research and education for triple-negative breast cancer.
The problem
Triple-negative breast cancer is aggressive and harder to treat than other breast cancers. It affects many patients with limited treatment options available.
The proposal
The bill directs federal funding toward research programs and educational initiatives specifically focused on triple-negative breast cancer treatment and prevention.
The impact
Breast cancer patients, researchers, and medical institutions benefit from increased funding. Healthcare costs and treatment outcomes may improve with better research.
Dedicated funding can accelerate discovery of new treatments for an aggressive cancer type. Researchers can conduct more studies with resources they currently lack.
Better research leads to more treatment options and earlier detection methods. Patients gain access to improved therapies as knowledge grows.
Education components help patients and doctors recognize symptoms earlier. Community awareness can lead to better prevention strategies.
Federal research funding strengthens domestic cancer research capabilities. This positions the U.S. as a leader in medical breakthroughs.
New federal funding adds to the national budget and deficit. Critics argue existing health budgets should be reallocated instead.
Dedicating funds to one cancer type means less money for other diseases. Other health conditions may receive reduced research support.
Research breakthroughs are unpredictable and may take many years. Funding does not guarantee practical treatments will be developed.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.